Stanley S. Schocket, M.D., F.A.C.S.

Dr. Schocket finished his residency at the St. Louis Hospital along with fellowship training at McMillan Barnes Hospital in 1963. He returned and began a career in academic Ophthalmology by joining the University of Maryland’s newly formed Department of Ophthalmology. After one year of practice he obtained an NIH Fellowship Training Award for Retina training at the world famous McMillan Barnes Hospital under the pioneer tutelage of Dr. Paul Cibis. During his fellowship he noted that the scleral depressor which was basically a slightly modified sewing thimble, caused considerable pain and discomfort to most patients being examined. He developed a pencil shaped scleral depressor that allowed a painless exam of the peripheral retina. The scleral depressor now is used by fellow Ophthalmologists in the United States and many throughout the world.

Following the fellowship, he started what was to be a 30 year academic career at University of Maryland in the Department of Ophthalmology and became the Assistant Professor and Director of Retina Service. His initial research was devoted to demonstrating, for the first time, that the vertebrate natural lens exposed to hyperbaric oxygen showed chromosomal abnormalities and subsequent cataract formation. (Ref. 2-7 and 8-13). In 1982 he gave, what was considered, the best paper at the national meeting at the American Academy of Ophthalmology (Ref. 11) on the treatment of neovascular glaucoma which was later published in Ophthalmology. This tube shunt device changed the prognosis of neovascular glaucoma from 30% successful to 90% and no longer was neovascular glaucoma the leading cause of enucleated eyes. He was honored by being selected to teach a course in Anterior Chamber Tube Shunt to Encircling Band for 8 years at the annual meeting of the American Academy of Ophthalmology. He was accepted into the prestigious American Ophthalmologic Society for his thesis of the shunt device. The initial device was published in the Color Atlas of Ophthalmic Surgery and the subsequent revision will be published in 2007 in the Glaucoma Text published by Elsevier.

Prior to 1982 macular hole with localized detachment causing central blindness was not treated because no medical or surgical treatment was deemed possible. Dr. Schocket on the other hand felt that if a detachment surrounding a hole could be treated there might be some return of vision. His article entitled Laser Treatment of Macular Holes in 1980 was instrumental in the development of the current treatment of macular holes. In 1991 Dr. Schocket’s peer ophthalmologists selected him the Best Retinal Specialist in 1991 and was listed in a future article in Baltimore Magazine. He served as full Professor of Ophthalmology from 1973 to 1993 at which time he and two other Professors, Dr. Vinod Lakhanpal and Dr. Verinder Nirankari, formed the Eye Consultants of Maryland. He presently serves as Clinical Professor of Ophthalmology at University of Maryland, the Co-Director of Vitreoretinal Surgery at Union Memorial Hospital, and Co-Director of the Retina Service at Eye Consultants of Maryland.

He has continued to innovate while in private practice at Eye Consultants of Maryland. His latest challenge has been to address one of the main causes of neovascular glaucoma, central vein occlusion. He has brought to Maryland a new surgical approach which employs a 60 micron needle to inject TPA (clot buster) into the blocked retinal vein. This has resulted in improvement of vision in many and prevention of neovascular glaucoma in almost everyone.